DaVita(DVA)
Search documents
DaVita(DVA) - 2023 Q1 - Earnings Call Transcript
2023-05-09 00:05
Company Participants Conference Call Participants Operator Thank you, and welcome to our first quarter conference call. We appreciate your continued interest in our company. I'm Nic Eliason, Group Vice President of Investor Relations and joining me today are Javier Rodriguez, our CEO and Joel Ackerman, our CFO. I will now turn the call over to Javier Rodriguez. Before I get into the details about the quarter, I would like to elaborate on an area of our long-term strategy, which is to connect transitions of ...
DaVita(DVA) - 2023 Q1 - Quarterly Report
2023-05-07 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 1-14106 DAVITA INC. Delaware 51-0354549 (State of incorporation) (I.R.S. Employer Identification No.) 2000 16th Street ...
DaVita(DVA) - 2022 Q4 - Earnings Call Transcript
2023-02-23 02:41
Andrew Mok with UBS. Andrew Mok Great. Just a few numbers questions to follow up. Your D&A increased about $20 million sequentially. Is that from the new clinical IT investments? Or is there something else driving that DNA higher in the quarter? Is that a good number to think about for 2023 from a run rate perspective? Joel Ackerman Yes. I think modeling consolidated D&A for 2023, I'd say we don't expect that to change very much from the full year 2022. Andrew Mok So D&A will be flat even though it ticked u ...
DaVita(DVA) - 2022 Q4 - Annual Report
2023-02-21 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 1-14106 DAVITA INC. (Exact name of registrant as specified in charter) Delaware 51-0354549 (State of incorporation) (I.R.S. ...
DaVita(DVA) - 2022 Q3 - Quarterly Report
2022-10-30 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 1-14106 DAVITA INC. Delaware 51-0354549 (State of incorporation) (I.R.S. Employer Identification No.) 2000 16th St ...
DaVita(DVA) - 2022 Q3 - Earnings Call Transcript
2022-10-28 19:47
DaVita Inc. (NYSE:DVA) Q3 2022 Earnings Conference Call October 28, 2022 8:30 AM ET Company Participants Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Andrew Mok - UBS Kevin Fischbeck - Bank of America Pito Chickering - Deutsche Bank Justin Lake - Wolfe Research Operator Good morning. My name is Amanda, and I will be your conference facilitator today. At this time, I would like to welcome everyone to the DaVita Third Quarter 2022 Earnings Cal ...
DaVita(DVA) - 2022 Q2 - Earnings Call Transcript
2022-08-02 03:36
DaVita Inc. (NYSE:DVA) Q2 2022 Earnings Conference Call August 1, 2022 5:00 PM ET Corporate Participants Joel Ackerman - Chief Financial Officer and Treasurer Javier Rodriguez - Chief Executive Officer Conference Call Participants Kevin Fischbeck - Bank of America Justin Lake - Wolfe Research Pito Chickering - Deutsche Bank Sarah James - Barclays Gary Taylor - Cowen Operator Good evening. My name is Michelle, and IÂ'll be your conference facilitator today. At this time, IÂ'd like to welcome everyone to the ...
DaVita(DVA) - 2022 Q2 - Quarterly Report
2022-07-31 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 1-14106 DAVITA INC. Delaware 51-0354549 (State of incorporation) (I.R.S. Employer Identification No.) 2000 16th Street ...
DaVita(DVA) - 2022 Q1 - Earnings Call Transcript
2022-05-06 02:46
DaVita Inc. (NYSE:DVA) Q1 2022 Results Conference Call May 5, 2022 5:00 PM ET Company Participants Joel Ackerman - CFO and Treasurer Javier Rodriguez - CEO Conference Call Participants Kevin Fischbeck - Bank of America Justin Lake - Wolfe Research Pito Chickering - Deutsche Bank Operator Good evening. My name is Missy, and IÂ'll be your conference facilitator today. At this time, IÂ'd like to welcome everyone to the DaVita First Quarter 2022 Earnings Call. [Operator Instructions] Thank you. Mr. Ackerman, yo ...
DaVita(DVA) - 2022 Q1 - Quarterly Report
2022-05-04 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | |--------------------------------------|------------------------------------------|--------------------| | | | | | For the | transition period from ___________ | to ___________ | | ...